Ann: R&D Heads of Agreement with Osmoflo, page-8

Where are the buyers??

If the new company looking at the tech was such fantastic news, I'd expect buyers to be lining up to purchase shares at the supposedly cheap current price, but they simply are not there!!

There is only one order of more than 1000 shares above 21c!!

The market is now thinner than it was, with holders having almost no option but to hold because of lack of buyers.

All those bullish words by quite a few posters here, yet they are not lining up to purchase more. It's been hard enough to sell out before, but after management showing incompetence by releasing an announcement they had to retract great swaths of, who would want to buy? Right now the answer is no-one, with no decent buys anywhere near the last sale price. Instead of there being a reasonable market for shares, poor performance by management has led to a dearth of buyers or interest in the stock.

The current, but falling Mcap of $62m is way overpriced for a single existing tech license that might make it's way into a couple of products in the next year or 2 (but that has been promissed for the last 5 years!!). Even if both Aspen and Osmoflo take on the FRG into a product or 2, profits for the company would be years away at best.

None of the products would be a mass market product IMHO, and given the main production company will be the main profit centre, revenue to Purifloh would be very skinny for years, maybe forever.
Where does cash as in millions come from for Purifloh with a few units say hundreds/yr selling come from?? Revenue assuming hundreds of sales of each would only amount to thousands, with corporate costs eating all of it and continual cap raisings necessary.

If management were the ants pants as claimed by @tukebay on many occasions, then retractions of announcements (because they didn't understand the ASX rules), spelling errors in announcements, late quarterlies (like last year) etc simply wouldn't happen.

Where are the buyers if @tukebay is correct??